Molecular Basis of Pathogenesis in RNA virus infection
Molecular Basis of "Shut-off" mechanism by RNA virus.
Study on Modification of Cell Growth Regulation by Hepatitis C Virus
全件表示
論文 (144件):
Mya Myat Ngwe Tun, Khine Mya Nwe, Jean Claude Balingit, Yuki Takamatsu, Shingo Inoue, Basu Dev Pandey, Takeshi Urano, Michinori Kohara, Kyoko Tsukiyama-Kohara, Kouichi Morita. A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis. Vaccines. 2023. 11. 12. 1857-1857
Kazi Anowar Hossain, Rupaly Akhter, Md Haroon Or Rashid, Lipi Akter, Masashi Utsunomiya, Bouchra Kitab, NgweTun Mm, Takayuki Hishiki, Michinori Kohara, Kouichi Morita, et al. Suppression of dengue virus replication by the French maritime pine extract Pycnogenol®. Virus research. 2023. 199244-199244
Kenzaburo Yamaji, Sadahiro Iwabuchi, Yuko Tokunaga, Shinichi Hashimoto, Daisuke Yamane, Sakiko Toyama, Risa Kono, Bouchra Kitab, Kyoko Tsukiyama-Kohara, Yosuke Osawa, et al. Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023. 166. 115379-115379
Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara. Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview. International journal of molecular sciences. 2023. 24. 11
Genki Ushirozako, Yutaro Noda, Norie Murayama, Hiroaki Kawaguchi, Kyoko Tsukiyama-Kohara, Hiroshi Yamazaki, Yasuhiro Uno. Newly Identified Tree Shrew Cytochrome P450 2A13 is Expressed in Liver and Lung and Encodes a Functional Drug-Metabolizing Enzyme Similar to Dog Cytochrome P450 2A13 and Pig Cytochrome P450 2A19. Drug metabolism and disposition: the biological fate of chemicals. 2023. 51. 5. 610-617
Osamu Yoshida, Yusuke Imai, Kana Shiraishi, Takahiro Sanada, Michinori Kohara, Kyoko Tsukiyama-Kohara, Takashi Miyazaki, Taizou Kamishita, Mamun Mahtab, Julio C. Aguilar, et al. LONG TERM HBsAg REDUCTION BY A NASAL ADMINISTRATIVE THERAPEUTIC VACCINE CONTAINING HBsAg AND HBCAG MIXED WITH MUCOADHESIVE CVP (CVP-NASVAC) IN PATIENTS WITH CHRONIC HBV INFECTION: THE RESULTS OF 30 MONTHS FOLLOW UP. HEPATOLOGY. 2021. 74. 64A-64A
Osamu Yoshida, Kana Shiraishi, Takahiro Sanada, Michinori Kohara, Kyoko Tsukiyama-Kohara, Takashi Miyazaki, Taizou Kamishita, Mamun Mahtab, Julio C. Aguilar, Gerardo E. Guillen, et al. HIGH ANTI-HBS INDUCTION BY RETREATMENT OF A NASAL ADMINISTRATIVE THERAPEUTIC VACCINE CONTAINING HBsAg AND HBCAG MIXED WITH MUCOADHESIVE CVP (CVP-NASVAC) IN CHRONIC HBV INFECTED PATIENTS. HEPATOLOGY. 2021. 74. 507A-508A